RESUMO
Bat-borne zoonotic pathogens belonging to the family Paramxyoviridae, including Nipah and Hendra viruses, and the family Filoviridae, including Ebola and Marburg viruses, can cause severe disease and high mortality rates on spillover into human populations. Surveillance efforts for henipaviruses and filoviruses have been largely restricted to the Old World; however, recent studies suggest a potentially broader distribution for henipaviruses and filoviruses than previously recognized. In the current study, we screened for henipaviruses and filoviruses in New World bats collected across 4 locations in Trinidad near the coast of Venezuela. Bat tissue samples were screened using previously established reverse-transcription polymerase chain reaction assays. Serum were screened using a multiplex immunoassay to detect antibodies reactive with the envelope glycoprotein of viruses in the genus Henipavirus and the family Filoviridae. Serum samples were also screened by means of enzyme-linked immunosorbent assay for antibodies reactive with Nipah G and F glycoproteins. Of 84 serum samples, 28 were reactive with ≥1 henipavirus glycoprotein by ≥1 serological method, and 6 serum samples were reactive against ≥1 filovirus glycoproteins. These data provide evidence of potential circulation of viruses related to the henipaviruses and filoviruses in New World bats.
Assuntos
Quirópteros/virologia , Infecções por Filoviridae/veterinária , Filoviridae , Infecções por Henipavirus/veterinária , Henipavirus , Animais , Quirópteros/sangue , Quirópteros/classificação , Infecções por Filoviridae/epidemiologia , Infecções por Filoviridae/virologia , Infecções por Henipavirus/epidemiologia , Infecções por Henipavirus/virologia , Testes Sorológicos , Trinidad e Tobago/epidemiologiaRESUMO
Marburg and Ebola viruses are emerging pathogens recognized since 1967, and in 1976, when they were first identified. These viruses are the only members of the Filoviridae family. They cause severe, frequently fatal, hemorrhagic fever. Each genus includes some serotypes with the distinctive characteristics to cause high mortality rate during outbreaks. The Ebola-Zaire subtype is the most lethal variant. The epidemiology of human pathogenic filovirus is reviewed in this paper considering the most relevant facts. Primary human cases arise probably through close contact with infected primates. This point may be the key to preventing the introduction of these viruses in human populations. Once introduced in humans, the infection may spread through close contact with infected individuals or their body fluids, particularly in hospital environments. A main feature of filovirus outbreaks is the occurrence of cycles of secondary infection.
Assuntos
Ebolavirus , Doença pelo Vírus Ebola/epidemiologia , Filoviridae , Infecções por Filoviridae , África , Ecologia , Febres Hemorrágicas Virais/epidemiologiaRESUMO
No other clinical entity has attached more attention now-a-day than those precipitated by the infection with a Hemorrhagic Fever Virus. Potentially caused by Arena, Bunya, Flavi, and Filoviradae, only the latter has had such a major impact throughout the world. Two major genuses have been recognized since they become evident for the first time in 1967, the single-species Marburg, and the 3-species-Ebola (E. zaire, sudan and reston). With the exception of the 2 outbreaks of E. reston (Washington, USA 1989-1993), all of them have taken place in Africa, where the virus is still hiding among the wild-life of the Tropical Rain Forest. Currently (in April 1995) the reemergence of Ebola virus has once more proven its fatality, leaving around 170 deaths in Zaire, 250 miles from its capital, Kinshasa. There is worldwide alert, sponsored by the CDC in Atlanta, the World Health Organization and the authorities in Zaire regarding its potential spreading to naive regions, in and out of Africa. The characteristic clinical picture of a viral hemorrhagic fever has no match. After a 2-21 days incubation period a viral-like illness develops. As days go by, symptoms worsen, and by the 7th day, a severe and diffuse bleeding tendency ensues. The individual's death is the most likely outcome in the great majority of cases. As a lethal virus, without an available treatment and a possible airborne-route of transmission, Ebola virus will always be considered a persistent threat to the global health
Assuntos
Humanos , Ebolavirus , Doença pelo Vírus Ebola , Surtos de Doenças , Ebolavirus , Doença pelo Vírus Ebola/complicações , Doença pelo Vírus Ebola/diagnóstico , Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/terapia , Filoviridae/patogenicidade , VirulênciaRESUMO
No other clinical entity has attached more attention now-a-day than those precipitated by the infection with a Hemorrhagic Fever Virus. Potentially caused by Arena, Bunya, Flavi, and Filoviradae, only the latter has had such a major impact throughout the world. Two major genuses have been recognized since they become evident for the first time in 1967, the single-species Marburg, and the 3-species-Ebola (E. zaire, sudan and reston). With the exception of the 2 outbreaks of E. reston (Washington, USA 1989-1993), all of them have taken place in Africa, where the virus is still hiding among the wild-life of the Tropical Rain Forest. Currently (in April 1995) the reemergence of Ebola virus has once more proven its fatality, leaving around 170 deaths in Zaire, 250 miles from its capital, Kinshasa. There is worldwide alert, sponsored by the CDC in Atlanta, the World Health Organization and the authorities in Zaire regarding its potential spreading to naive regions, in and out of Africa. The characteristic clinical picture of a viral hemorrhagic fever has no match. After a 2-21 days incubation period a viral-like illness develops. As days go by, symptoms worsen, and by the 7th day, a severe and diffuse bleeding tendency ensues. The individual's death is the most likely outcome in the great majority of cases. As a lethal virus, without an available treatment and a possible airborne-route of transmission, Ebola virus will always be considered a persistent threat to the global health.
Assuntos
Ebolavirus/patogenicidade , Doença pelo Vírus Ebola , Surtos de Doenças , Ebolavirus/classificação , Filoviridae/patogenicidade , Doença pelo Vírus Ebola/complicações , Doença pelo Vírus Ebola/diagnóstico , Doença pelo Vírus Ebola/epidemiologia , Doença pelo Vírus Ebola/terapia , Humanos , VirulênciaRESUMO
La familia Filoviridae esta compuesta por cuatro virus: Marburg y tres subtipos de Ebola (Ebola Zaire, Ebola Sudán y Ebola Reston). El género de los filovirus son muy similares morfológicamente y en densidad; son visualizados como partículas pleomórficas, grandes y filamentosas, frecuentemente adquieren configuraciones circulares o en U. La longitud del virión es variable (hasta 14000nm) pero el diámetro es uniforme en 80 nm. El virus consta de una nucleocápside, rodeada por una cápside helicoidal; hay un canal axial en la nucleocápside, una membrana formada por proyecciones de 10 nm, y todo el virión está cubierto por una unidad de lipoproteína derivada de la célula huésped. El genoma consta de una molécula de una cadena única de polaridad negativa de RNA que no es infeccioso por sí mismo, cuyo orden es: región 3I, nucleoproteína, proteína viral estructural, VP35, glicoproteína VP40, VP30, VP24, polimerasa (L) y región 5I